• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性肿瘤中免疫逃逸机制的表观遗传调控

Epigenetic control of the immune escape mechanisms in malignant carcinomas.

作者信息

Setiadi A Francesca, David Muriel D, Seipp Robyn P, Hartikainen Jennifer A, Gopaul Rayshad, Jefferies Wilfred A

机构信息

Biomedical Research Centre, Vancouver, British Columbia V6T 1Z3, Canada.

出版信息

Mol Cell Biol. 2007 Nov;27(22):7886-94. doi: 10.1128/MCB.01547-07. Epub 2007 Sep 17.

DOI:10.1128/MCB.01547-07
PMID:17875943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2169144/
Abstract

Downregulation of the transporter associated with antigen processing 1 (TAP-1) has been observed in many tumors and is closely associated with tumor immunoevasion mechanisms, growth, and metastatic ability. The molecular mechanisms underlying the relatively low level of transcription of the tap-1 gene in cancer cells are largely unexplained. In this study, we tested the hypothesis that epigenetic regulation plays a fundamental role in controlling tumor antigen processing and immune escape mechanisms. We found that the lack of TAP-1 transcription in TAP-deficient cells correlated with low levels of recruitment of the histone acetyltransferase, CBP, to the TAP-1 promoter. This results in lower levels of histone H3 acetylation at the TAP-1 promoter, leading to a decrease in accessibility of the RNA polymerase II complex to the TAP-1 promoter. These observations suggest that CBP-mediated histone H3 acetylation normally relaxes the chromatin structure around the TAP-1 promoter region, allowing transcription. In addition, we found a hitherto-unknown mechanism wherein interferon gamma up-regulates TAP-1 expression by increasing histone H3 acetylation at the TAP-1 promoter locus. These findings lie at the heart of understanding immune escape mechanisms in tumors and suggest that the reversal of epigenetic codes may provide novel immunotherapeutic paradigms for intervention in cancer.

摘要

在许多肿瘤中都观察到与抗原加工相关的转运体1(TAP-1)的下调,并且它与肿瘤免疫逃逸机制、生长及转移能力密切相关。癌细胞中tap-1基因转录水平相对较低的分子机制在很大程度上尚不清楚。在本研究中,我们检验了表观遗传调控在控制肿瘤抗原加工和免疫逃逸机制中起关键作用这一假说。我们发现,TAP缺陷细胞中TAP-1转录的缺失与组蛋白乙酰转移酶CBP募集到TAP-1启动子的水平较低相关。这导致TAP-1启动子处组蛋白H3乙酰化水平降低,进而导致RNA聚合酶II复合物与TAP-1启动子的结合能力下降。这些观察结果表明,CBP介导的组蛋白H3乙酰化通常会使TAP-1启动子区域周围的染色质结构松弛,从而允许转录。此外,我们发现了一种前所未知的机制,即干扰素γ通过增加TAP-1启动子位点的组蛋白H3乙酰化来上调TAP-1表达。这些发现是理解肿瘤免疫逃逸机制的核心所在,并表明表观遗传密码的逆转可能为癌症干预提供新的免疫治疗模式。

相似文献

1
Epigenetic control of the immune escape mechanisms in malignant carcinomas.恶性肿瘤中免疫逃逸机制的表观遗传调控
Mol Cell Biol. 2007 Nov;27(22):7886-94. doi: 10.1128/MCB.01547-07. Epub 2007 Sep 17.
2
Identification of mechanisms underlying transporter associated with antigen processing deficiency in metastatic murine carcinomas.转移性小鼠癌中与抗原加工缺陷相关转运蛋白潜在机制的鉴定。
Cancer Res. 2005 Aug 15;65(16):7485-92. doi: 10.1158/0008-5472.CAN-03-3734.
3
Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors.抗原加工与呈递的表观遗传增强促进肿瘤的免疫识别。
Cancer Res. 2008 Dec 1;68(23):9601-7. doi: 10.1158/0008-5472.CAN-07-5270.
4
IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma.γ干扰素介导的人肾细胞癌中人类TAP-1和LMP-2基因的协同转录调控
Clin Cancer Res. 1997 Apr;3(4):573-8.
5
17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter.17β-雌二醇抑制II类主要组织相容性复合体(MHC)表达:对组蛋白修饰及CBP募集至II类MHC启动子的影响
Mol Endocrinol. 2004 Aug;18(8):1963-74. doi: 10.1210/me.2004-0098. Epub 2004 May 13.
6
Chicken TAP genes differ from their human orthologues in locus organisation, size, sequence features and polymorphism.鸡的TAP基因在基因座组织、大小、序列特征和多态性方面与其人类同源基因不同。
Immunogenetics. 2005 May;57(3-4):232-47. doi: 10.1007/s00251-005-0786-2. Epub 2005 Apr 2.
7
Expression and function of the peptide transporters in escape variants of human renal cell carcinomas.肽转运体在人肾细胞癌逃逸变体中的表达与功能
Exp Hematol. 1997 Jul;25(7):608-14.
8
Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.在低TAP和LMP表达的一部分人类肾细胞癌中,膜主要组织相容性复合体I类密度降低且稳定性下降。
Clin Cancer Res. 1996 Aug;2(8):1427-33.
9
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.爱泼斯坦-巴尔病毒潜伏膜蛋白1恢复伯基特淋巴瘤细胞内源性抗原加工:肽转运体和HLA-I类抗原表达的协同上调
Eur J Immunol. 1995 May;25(5):1374-84. doi: 10.1002/eji.1830250536.
10
The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP2.在人类子宫平滑肌肉瘤中发现的JAK1的ATP结合区域突变,导致TAP1和LMP2的干扰素-γ诱导性缺陷。
Oncogene. 2006 Jul 6;25(29):4016-26. doi: 10.1038/sj.onc.1209434. Epub 2006 Feb 13.

引用本文的文献

1
A novel type-2 innate lymphoid cell-based immunotherapy for cancer.一种新型基于 2 型先天淋巴细胞的癌症免疫疗法。
Front Immunol. 2024 Mar 7;15:1317522. doi: 10.3389/fimmu.2024.1317522. eCollection 2024.
2
Aspartate β-hydroxylase Regulates Expression of Genes.天冬氨酸β-羟化酶调节基因表达。
J Cancer. 2024 Jan 1;15(5):1138-1152. doi: 10.7150/jca.90422. eCollection 2024.
3
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit.头颈癌中的免疫逃逸策略:逃避、抵抗、抑制、招募。
Cancers (Basel). 2024 Jan 11;16(2):312. doi: 10.3390/cancers16020312.
4
A diversity of novel type-2 innate lymphoid cell subpopulations revealed during tumour expansion.在肿瘤扩张过程中发现了多种新型 2 型先天淋巴细胞亚群。
Commun Biol. 2024 Jan 3;7(1):12. doi: 10.1038/s42003-023-05536-0.
5
Curcuphenol possesses an unusual histone deacetylase enhancing activity that counters immune escape in metastatic tumours.curcuphenol具有一种不同寻常的组蛋白去乙酰化酶增强活性,可对抗转移性肿瘤中的免疫逃逸。
Front Pharmacol. 2023 Aug 10;14:1119620. doi: 10.3389/fphar.2023.1119620. eCollection 2023.
6
A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours.一种基于细胞的新型筛选方法可识别出能逆转转移性肿瘤免疫逃逸表型的化学实体。
Front Pharmacol. 2023 May 15;14:1119607. doi: 10.3389/fphar.2023.1119607. eCollection 2023.
7
Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer.癌症睾丸抗原的生物学特性及其在癌症治疗中的意义。
Cells. 2023 Mar 17;12(6):926. doi: 10.3390/cells12060926.
8
Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours.特定的大麻素通过逆转转移性肿瘤中的免疫逃逸机制来恢复适应性免疫。
Front Immunol. 2023 Feb 22;13:982082. doi: 10.3389/fimmu.2022.982082. eCollection 2022.
9
Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities.探索胶质母细胞瘤干细胞异质性:免疫微环境调节与治疗机遇。
Front Oncol. 2022 Sep 21;12:995498. doi: 10.3389/fonc.2022.995498. eCollection 2022.
10
Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potential.癌睾丸抗原 PRAME:具有免疫调节潜力的抗癌靶点。
J Cell Mol Med. 2021 Nov;25(22):10376-10388. doi: 10.1111/jcmm.16967. Epub 2021 Oct 6.

本文引用的文献

1
Dynamic chromatin: concerted nucleosome remodelling and acetylation.动态染色质:协同的核小体重塑与乙酰化作用
Biol Chem. 2005 Aug;386(8):745-51. doi: 10.1515/BC.2005.087.
2
Identification of mechanisms underlying transporter associated with antigen processing deficiency in metastatic murine carcinomas.转移性小鼠癌中与抗原加工缺陷相关转运蛋白潜在机制的鉴定。
Cancer Res. 2005 Aug 15;65(16):7485-92. doi: 10.1158/0008-5472.CAN-03-3734.
3
Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells.人乳腺癌细胞中蛋白磷酸酶2A(PP2A)、淋巴细胞趋化因子(XCL1)和雌激素受体α(ER)表达的表观遗传调控
Cancer Biol Ther. 2004 Dec;3(12):1304-12. doi: 10.4161/cbt.3.12.1458. Epub 2004 Dec 9.
4
Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.HPV16相关肿瘤的免疫逃逸表型:MHC I类分子表达在进展和治疗过程中的变化
Int J Oncol. 2005 Feb;26(2):521-7.
5
Epigenetics and cancer.表观遗传学与癌症。
Genes Dev. 2004 Oct 1;18(19):2315-35. doi: 10.1101/gad.1232504.
6
CBP and p300: HATs for different occasions.CBP和p300:适用于不同场合的组蛋白乙酰转移酶
Biochem Pharmacol. 2004 Sep 15;68(6):1145-55. doi: 10.1016/j.bcp.2004.03.045.
7
Phosphorylation and acetylation of histone H3 at inducible genes: two controversies revisited.诱导型基因上组蛋白H3的磷酸化与乙酰化:对两个争议点的重新审视
Novartis Found Symp. 2004;259:102-11; discussion 111-4, 163-9.
8
Regulating histone acetyltransferases and deacetylases.调控组蛋白乙酰转移酶和去乙酰化酶。
EMBO Rep. 2003 Oct;4(10):944-7. doi: 10.1038/sj.embor.embor941.
9
Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules.用修饰的人乳头瘤病毒16型E7基因对主要组织相容性复合体I类分子表达下调的小鼠致癌TC-1细胞亚系进行免疫接种。
Vaccine. 2003 Mar 7;21(11-12):1125-36. doi: 10.1016/s0264-410x(02)00519-4.
10
The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer.新型BORIS + CTCF基因家族独特地参与正常生物学和癌症的表观遗传学过程。
Semin Cancer Biol. 2002 Oct;12(5):399-414. doi: 10.1016/s1044-579x(02)00060-3.